MARKET

AYTU

AYTU

Aytu Biopharma Inc
NASDAQ
2.290
-0.100
-4.18%
After Hours: 2.290 0 0.00% 16:10 02/09 EST
OPEN
2.380
PREV CLOSE
2.390
HIGH
2.420
LOW
2.280
VOLUME
77.09K
TURNOVER
--
52 WEEK HIGH
3.065
52 WEEK LOW
0.9500
MARKET CAP
24.58M
P/E (TTM)
-1.0221
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AYTU last week (0202-0206)?
Weekly Report · 12h ago
Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Aytu BioScience (AYTU)
TipRanks · 4d ago
Full Transcript: Aytu BioPharma Q2 2026 Earnings Call
Benzinga · 5d ago
Lake Street Remains a Buy on Aytu BioScience (AYTU)
TipRanks · 5d ago
Aytu BioPharma outlines EXXUA launch strategy and expects breakeven at $17.3M quarterly net revenue as ADHD portfolio remains resilient
Seeking Alpha · 5d ago
Aytu Biopharma stellt neue Unternehmenspräsentation mit Fokus auf Therapien für Depression und ADHS vor
Reuters · 5d ago
Aytu Biopharma Inc. unveils new corporate presentation highlighting CNS drug portfolio and strategic realignment
Reuters · 5d ago
Aytu BioPharma AYTU Q2 2026 Earnings Transcript
NASDAQ · 5d ago
More
About AYTU
Aytu BioPharma, Inc. is a pharmaceutical company focused on advancing medicines for complex central nervous system (CNS) diseases. Its business is focused on the launch of EXXUA and its prescription pharmaceutical products sold primarily through third-party wholesalers and pharmacies and which primarily consists of two product portfolios. Its Attention Deficit Hyperactivity Disorder (ADHD) portfolio consists of Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) , Cotempla XR-ODT, and METADATE CD, which are CNS stimulants indicated for the treatment of ADHD in patients. Its Pediatric portfolio consists of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine indicated to treat various allergic conditions including seasonal and perennial allergic rhinitis, vasomotor rhinitis, Poly-Vi-Flor, and Tri-Vi-Flor. EXXUA is indicated to treat depressive disorder (MDD) in adults.

Webull offers Aytu Biopharma Inc stock information, including NASDAQ: AYTU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AYTU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AYTU stock methods without spending real money on the virtual paper trading platform.